The lung cross-species signature includes multiple carcinoma-associated genes (TNR, SCD) and, to a lesser extent, genes involved in complement deficiency (CFD, C3) and NAD+ metabolism (NNMT), all of which may be considered aging-associated processes [22-24]. The gene discussed is C3; the disease is carcinoma.